Vasopressin (AVP / ADH): A Tracking Guide for a Pituitary Hormone

Vasopressin (also known as arginine vasopressin, AVP, or antidiuretic hormone, ADH) is a 9-amino-acid peptide hormone produced in the hypothalamus and released from the posterior pituitary. Its core jobs are water retention at the kidneys and vasoconstriction. Clinically it is used for central diabetes insipidus and as a vasopressor in septic shock and certain cardiac arrest contexts. Self-experimenter use is rare and the safety margin is narrow.

What it does

AVP binds V1, V2, and V3 receptors. V2 receptors at the kidney drive water reabsorption (the antidiuretic effect). V1 receptors on vascular smooth muscle drive vasoconstriction. V3 (V1b) receptors are pituitary and modulate ACTH release. Synthetic analogs like desmopressin (DDAVP) are V2-selective and are what most clinical antidiuretic use actually involves — not native vasopressin.

Typical protocol shape

This is one of the cleaner cases for "this is a clinical drug, not a self-experimenter peptide." Native vasopressin is used:

• IV infusion in critical care
• Short-acting injectable in specific clinical contexts
• Not chronically self-administered

If you are tracking desmopressin (DDAVP) for nocturia, central DI, or other prescribed indications, that is a different post.

What to track daily

If a physician has prescribed vasopressin or an analog and you are tracking adherence and response:

• Dose, route, time
• Fluid intake (ml)
• Urine output (ml) and frequency
• Body weight (same time, same scale) — sudden gain can indicate water retention
• Blood pressure (multiple readings)
• Headache, nausea, confusion (early signs of hyponatremia)
• Skin color and warmth in extremities

What to track weekly

• Average daily fluid in and out
• Weight trend
• Blood pressure trend
• Sleep quality

Bloodwork worth doing

Mandatory for chronic AVP-axis intervention:

• Serum sodium — the most important single value
• Serum osmolality
• Urine osmolality and sodium
• BUN and creatinine
• CMP

Frequency depends on indication and physician guidance. For prescribed long-term desmopressin use, periodic sodium checks are standard of care.

Realistic expectations

Vasopressin is not a wellness peptide. Outside its clinical indications it does not have a self-experimenter use case with a meaningful evidence base. The two failure modes are serious: hyponatremia from too much water retention, and ischemia from too much vasoconstriction. Neither is a "log it and learn" situation — both can put you in the hospital.

Common mistakes

• Treating vasopressin like a nootropic. Old anecdotal claims about memory effects do not justify the cardiovascular and electrolyte risks.
• Free-water intake on top of antidiuretic dosing. This is how hyponatremia happens.
• Not measuring sodium. Symptoms appear after the lab value is already concerning.
• Confusing vasopressin with desmopressin. They are not interchangeable.

A tracking template

If you are on prescribed therapy:

• Daily fluid in, fluid out, weight, blood pressure
• Weekly: review trend, flag any unexpected weight gain or BP shifts
• Periodic sodium checks per physician schedule
• Log every dose in Peptide IA with route and time

Safety notes

This is genuinely a physician-only peptide for most use cases. Hyponatremia is potentially fatal. Cardiac and peripheral ischemia are real risks. If you do not have a clinical indication, a prescribing physician, and access to electrolyte monitoring, this is not a peptide to self-experiment with.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.